Sachin A Gharat1, Balkrishna A Shinde1,2, Ravindra D Mule3,4, Sachin A Punekar5, Bhushan B Dholakia1,6, Ramesha H Jayaramaiah1,7,8, Gopalakrishna Ramaswamy7, Ashok P Giri9. 1. Biochemical Sciences Division, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India. 2. Department of Biotechnology, Shivaji University, Vidyanagar, Kolhapur, 416004, India. 3. Division of Organic Chemistry, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India. 4. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. 5. Biospheres, Eshwari, 52/403, Lakshmi nagar, Parvati, Pune, 411009, India. 6. Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India. 7. Theracues Innovations Private Limited, Sahakar nagar, Bangalore, 560092, India. 8. Hawkesbury Institute for the Environment, Western Sydney University, Penrith, NSW, 2751, Australia. 9. Biochemical Sciences Division, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune, 411008, India. ap.giri@ncl.res.in.
Abstract
MAIN CONCLUSION: Exploration with high-throughput transcriptomics and metabolomics of two varieties of Ceropegia bulbosa identifies candidate genes, crucial metabolites and a potential cerpegin biosynthetic pathway. Ceropegia bulbosa is an important medicinal plant, used in the treatment of various ailments including diarrhea, dysentery, and syphilis. This is primarily attributed to the presence of pharmaceutically active secondary metabolites, especially cerpegin. As this plant belongs to an endemic threatened category, genomic resources are not available hampering exploration on the molecular basis of cerpegin accumulation till now. Therefore, we undertook high-throughput metabolomic and transcriptomic analyses using different tissues from two varieties namely, C. bulbosa var. bulbosa and C. bulbosa var. lushii. Metabolomic analysis revealed spatial and differential accumulation of various metabolites. We chemically synthesized and characterized the cerpegin and its derivatives by liquid chromatography tandem-mass spectrometry (LC-MS/MS). Importantly, these comparisons suggested the presence of cerpegin and 5-allyl cerpegin in all C. bulbosa tissues. Further, de novo transcriptome analysis indicated the presence of significant transcripts for secondary metabolic pathways through the Kyoto encyclopedia of genes and genomes database. Tissue-specific profiling of transcripts and metabolites showed a significant correlation, suggesting the intricate mechanism of cerpegin biosynthesis. The expression of potential candidate genes from the proposed cerpegin biosynthetic pathway was further validated by qRT-PCR and NanoString nCounter. Overall, our findings propose a potential route of cerpegin biosynthesis. Identified transcripts and metabolites have built a foundation as new molecular resources that could facilitate future research on biosynthesis, regulation, and engineering of cerpegin or other important metabolites in such non-model plants.
MAIN CONCLUSION: Exploration with high-throughput transcriptomics and metabolomics of two varieties of Ceropegia bulbosa identifies candidate genes, crucial metabolites and a potential cerpegin biosynthetic pathway. Ceropegia bulbosa is an important medicinal plant, used in the treatment of various ailments including diarrhea, dysentery, and syphilis. This is primarily attributed to the presence of pharmaceutically active secondary metabolites, especially cerpegin. As this plant belongs to an endemic threatened category, genomic resources are not available hampering exploration on the molecular basis of cerpegin accumulation till now. Therefore, we undertook high-throughput metabolomic and transcriptomic analyses using different tissues from two varieties namely, C. bulbosa var. bulbosa and C. bulbosa var. lushii. Metabolomic analysis revealed spatial and differential accumulation of various metabolites. We chemically synthesized and characterized the cerpegin and its derivatives by liquid chromatography tandem-mass spectrometry (LC-MS/MS). Importantly, these comparisons suggested the presence of cerpegin and 5-allyl cerpegin in all C. bulbosa tissues. Further, de novo transcriptome analysis indicated the presence of significant transcripts for secondary metabolic pathways through the Kyoto encyclopedia of genes and genomes database. Tissue-specific profiling of transcripts and metabolites showed a significant correlation, suggesting the intricate mechanism of cerpegin biosynthesis. The expression of potential candidate genes from the proposed cerpegin biosynthetic pathway was further validated by qRT-PCR and NanoString nCounter. Overall, our findings propose a potential route of cerpegin biosynthesis. Identified transcripts and metabolites have built a foundation as new molecular resources that could facilitate future research on biosynthesis, regulation, and engineering of cerpegin or other important metabolites in such non-model plants.
Authors: Thilo Winzer; Valeria Gazda; Zhesi He; Filip Kaminski; Marcelo Kern; Tony R Larson; Yi Li; Fergus Meade; Roxana Teodor; Fabián E Vaistij; Carol Walker; Tim A Bowser; Ian A Graham Journal: Science Date: 2012-05-31 Impact factor: 47.728
Authors: Kirsten A Leiss; Federica Maltese; Young Hae Choi; Robert Verpoorte; Peter G L Klinkhamer Journal: Plant Physiol Date: 2009-05-15 Impact factor: 8.340
Authors: Shuqing Xu; Thomas Brockmöller; Aura Navarro-Quezada; Heiner Kuhl; Klaus Gase; Zhihao Ling; Wenwu Zhou; Christoph Kreitzer; Mario Stanke; Haibao Tang; Eric Lyons; Priyanka Pandey; Shree P Pandey; Bernd Timmermann; Emmanuel Gaquerel; Ian T Baldwin Journal: Proc Natl Acad Sci U S A Date: 2017-05-23 Impact factor: 11.205
Authors: Vladislav A Malkov; Kyle A Serikawa; Noel Balantac; James Watters; Gary Geiss; Afshin Mashadi-Hossein; Thomas Fare Journal: BMC Res Notes Date: 2009-05-09